We have located links that may give you full text access.
CONTROLLED CLINICAL TRIAL
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Gas permeable (GP) versus non-GP lens wearers: accuracy of orthokeratology in myopia reduction.
PURPOSE: The primary objective of this study is to determine whether there are significant differences in visual and refractive outcomes between gas permeable (GP) and non-GP wearers following a 1-month period of overnight orthokeratology (OK).
METHODS: The study included 14 subjects between the ages of 18 and 42 years. Group 1 consisted of six subjects wearing GP lenses for the correction of myopia for, at minimum, 1 year. Group 2 consisted of eight subjects wearing soft contact lenses or spectacles for the correction of myopia. All subjects were fit into the BE design in Boston XO material and lenses were worn for a period of 1 month. Unaided visual acuity using high (90%) and low (10%) contrast log MAR Bailey-Lovie vision charts, subjective refraction, corneal topography, and slit lamp evaluation were performed. Subjects were evaluated at day 1, 7, 14, 21, and 30.
RESULTS: One eye of each subject was considered for analysis; the eye with the better response was chosen based on post-OK measures. The mean post-OK spherical equivalent was 0.29 +/- 0.55 D in the GP group and 0.37 +/- 0.46 D in the non-GP group; the difference was statistically significant (p = 0.03). Baseline astigmatism decreased in the non-GP group after OK while there was no significant change in the GP group. The mean high contrast acuities were 0.06 +/- 0.12 in the GP group and 0.17 +/- 0.07 in the non-GP group (p = 0.05), whereas the low contrast acuities were 0.18 +/- 0.17 in the GP and 0.02 +/- 0.09 in the non-GP group (p = 0.01).
CONCLUSIONS: Although the non-GP group has higher post-OK visual acuity and spherical equivalent statistically, the GP group has attained an average unaided acuity of >20/20 and residual myopia <0.5 D. Clinically, this shows that OK can be a promising technique in GP wearers.
METHODS: The study included 14 subjects between the ages of 18 and 42 years. Group 1 consisted of six subjects wearing GP lenses for the correction of myopia for, at minimum, 1 year. Group 2 consisted of eight subjects wearing soft contact lenses or spectacles for the correction of myopia. All subjects were fit into the BE design in Boston XO material and lenses were worn for a period of 1 month. Unaided visual acuity using high (90%) and low (10%) contrast log MAR Bailey-Lovie vision charts, subjective refraction, corneal topography, and slit lamp evaluation were performed. Subjects were evaluated at day 1, 7, 14, 21, and 30.
RESULTS: One eye of each subject was considered for analysis; the eye with the better response was chosen based on post-OK measures. The mean post-OK spherical equivalent was 0.29 +/- 0.55 D in the GP group and 0.37 +/- 0.46 D in the non-GP group; the difference was statistically significant (p = 0.03). Baseline astigmatism decreased in the non-GP group after OK while there was no significant change in the GP group. The mean high contrast acuities were 0.06 +/- 0.12 in the GP group and 0.17 +/- 0.07 in the non-GP group (p = 0.05), whereas the low contrast acuities were 0.18 +/- 0.17 in the GP and 0.02 +/- 0.09 in the non-GP group (p = 0.01).
CONCLUSIONS: Although the non-GP group has higher post-OK visual acuity and spherical equivalent statistically, the GP group has attained an average unaided acuity of >20/20 and residual myopia <0.5 D. Clinically, this shows that OK can be a promising technique in GP wearers.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app